MeSH tree: D04.210.500.745.432
Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment responses in multiple myeloma patients by blocking a protein that plays a key role in drug resistance. ...
Apr 15, 2025
0
16
Thousands of Minnesotans remain exhausted and disabled after their COVID-19 illnesses, but why they got "long COVID" while millions of others who got sick did not remains a mystery.
Mar 19, 2025
0
13
In Europe, ten people died from measles in 2024, and the US has had several major outbreaks. Bird flu has affected dairy herds in 17 US states from North Carolina to California and has just been reported in cats. So far, ...
Mar 11, 2025
0
17
A new study of more than 2,900 patients provides evidence that it's likely best to use as little corticosteroid medicine as possible when treating people who have lupus pericarditis, a common heart complication of the autoimmune ...
Feb 26, 2025
0
17
For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard therapy is more efficacious for providing a complete renal response than standard therapy alone, according ...
Feb 26, 2025
0
14
Swelling caused by brain cancer is a serious problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses ...
Feb 26, 2025
0
28
A new rat study explores lung function and placental changes in the presence of infection and inflammation. The study suggests treating the mother with steroids before giving birth may improve both lung and placental function, ...
Feb 13, 2025
0
10
For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not negatively impact survival, according to a study published online Jan. 2 in Blood.
Jan 24, 2025
0
17
At the beginning of the COVID-19 pandemic, numerous studies had shown that COVID-19 patients with high levels of neutrophils, a key immune cell, presented with more severe disease and poor clinical outcomes. It was not clearly ...
Dec 18, 2024
0
21
Chimeric antigen receptor (CAR) T-cell therapy is a type of cancer immunotherapy where patients' T-cells are collected and genetically modified to produce chimeric antigen receptors that recognize specific targets on cancer ...
Dec 17, 2024
0
18
